Background illustration for clinical trials search

Paid Clinical Trials Dayton

Discover 1,187 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

for
Intracerebral Hemorrhage
Location: Cincinnati OH, Columbus OH, Detroit MI, Chicago IL,
Sponsor: Joseph Broderick, MD

Sex: All

Age: 18 - 70+

Code: NCT07227246

Phase 3, Recruiting

Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial

for
Metastatic Bone Disease
Location: Cincinnati OH, Fort Wayne IN, Aurora CO, Portland OR
Sponsor: Michelle Ghert, MD

Sex: All

Age: 18+

Code: NCT06863129

Recruiting

Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks

for
Mastectomy; Lymphedema, Breast Cancer
Location: Cincinnati OH
Sponsor: University of Cincinnati

Sex: All

Age: 18+

Code: NCT06574022

Recruiting

A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Cincinnati OH, Cleveland OH, Detroit MI, Madison WI,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06859762

Phase 1, Recruiting

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

for
Chronic Inflammatory Demyelinating Polyneuropathy, CIDP,
Location: Cincinnati OH, Nicholasville KY, Ann Arbor MI,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT06920004

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma

for
Head and Neck Cancer,
Location: Cincinnati OH
Sponsor: University of Cincinnati

Sex: All

Age: 18+

Code: NCT07213934

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

for
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Location: Cincinnati OH, North Canton OH, St Louis MO,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 65

Code: NCT06951711

Phase 3, Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

for
Multiple Sclerosis Spasticity
Location: Cincinnati OH, Columbus OH, Southfield MI, Knoxville TN,
Sponsor: Celgene

Sex: All

Age: 18 - 70

Code: NCT06782490

Phase 2, Recruiting

LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This

for
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,
Location: Cincinnati OH
Sponsor: Zulfa Omer

Sex: All

Age: 18+

Code: NCT06978088

Phase 2, Recruiting

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

for
Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma
Location: Cincinnati OH, Columbus OH, Charlottesville VA,
Sponsor: UroGen Pharma Ltd.

Sex: All

Age: 18+

Code: NCT06774131

Phase 3, Recruiting

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for
Lymphoma, Large B-Cell, Diffuse
Location: Cincinnati OH, Edgewood KY, Lexington KY, Louisville KY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06890884

Phase 2, Recruiting

Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors

for
Cancer, Metastatic Cancer, Locally Advanced,
Location: Cincinnati OH
Sponsor: University of Cincinnati

Sex: All

Age: 18+

Code: NCT06416007

Phase 2, Recruiting

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

for
Adult Acute Myeloid Leukemia
Location: Cincinnati OH, Cleveland OH, Detroit MI, Baltimore MD,
Sponsor: Priothera SAS

Sex: All

Age: 18 - 70+

Code: NCT05429632

Phase 3, Recruiting

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

for
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Location: Cincinnati OH, Columbus OH, Lexington KY, Louisville KY,
Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT05943535

Phase 3, Recruiting

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

for
Intracerebral Hemorrhage, Atrial Fibrillation
Location: Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT03907046

Phase 3, Recruiting

A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

for
Nasopharyngeal Cancer Recurrent
Location: Cincinnati OH, Ann Arbor MI, Cleveland OH, Detroit MI,
Sponsor: Coherus Oncology, Inc.

Sex: All

Age: 12+

Code: NCT06457503

Recruiting

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging

for
Stroke, Intracranial Atherosclerotic Stenosis (ICAS)
Location: Cincinnati OH, Cleveland OH, Chicago IL,
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT05907629

Recruiting

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

for
Systemic Sclerosis Associated Interstitial Lung Disease,
Location: Cincinnati OH, Ann Arbor MI, Pittsburgh PA, Chicago IL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05878717

Phase 2, Phase 3, Recruiting

Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer

for
Metastatic Microsatellite Stable Colorectal Carcinoma,
Location: Cincinnati OH, West Chester OH, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06654037

Phase 1, Recruiting

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

for
Acute Myeloid Leukemia,
Location: Cincinnati OH, West Chester OH, Columbus OH, Chicago IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05886049

Phase 1, Recruiting